Viewing StudyNCT00523315



Ignite Creation Date: 2024-05-05 @ 6:40 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00523315
Status: COMPLETED
Last Update Posted: 2011-05-20
First Post: 2007-08-30

Brief Title: APOLLOAromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Aromatase Inhibitor View
Breast Cancer View
compliance View
Naturalistic View
Observational View